Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$5,443,085
+$238,225 QoQ
Shares Held
21,432
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.08%
of 13F equity value
Holder Rank
#1,560
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MITCHELL SINKLER & STARR/PA holds $19,003,477 across 8 Drug Manufacturers - General names. JNJ ranks #2 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
42,391 | $5,447,243 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
21,432 | $5,443,085 | |
| 3 | ABBV |
AbbVie Inc.
|
13,417 | $3,376,253 | |
| 4 | LLY |
ELI LILLY & Co
|
1,998 | $2,396,461 | |
| 5 | AMGN |
Amgen Inc
|
2,295 | $831,065 | |
| 6 | PFE |
Pfizer Inc
|
27,742 | $668,027 | |
| 7 | NVS |
Novartis AG
|
3,193 | $500,406 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,917 | $340,937 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,443,085 | 21,432 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $5,204,860 | 21,293 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $4,479,846 | 21,647 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,054,393 | 21,866 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $3,361,416 | 22,006 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $10,749,582 | 64,819 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $9,926,716 | 68,640 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $13,835,224 | 85,371 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,368,763 | 77,783 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $12,478,976 | 78,886 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $21,001,122 | 133,987 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $15,434,669 | 99,099 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $13,482,762 | 81,457 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $12,628,935 | 81,477 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,723,746 | 72,028 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,342,248 | 69,431 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $11,937,725 | 67,251 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $11,799,796 | 66,579 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $11,330,137 | 66,231 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,454,961 | 15,201 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,533,865 | 15,381 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $2,559,093 | 15,571 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,815,842 | 17,892 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,850,158 | 19,144 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $2,560,731 | 18,209 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,386,434 | 18,199 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||